Discovering

A disciplined, highly targeted approach to discovering new cancer medicines

Go

Developing

Rigorous, definitive clinical trials based on deep oncology expertise

Go

Delivering

Committed to bringing differentiated new cancer medicines to patients

Go

Iclusig®(ponatinib)

ARIAD's first internally discovered and developed medicine

Go
       

News & Features

Latest News

7/29/15

ARIAD to Receive up to $200 Million Through Iclusig Non-Dilutive Synthetic-Royalty Financing with PDL BioPharma

Read More

7/22/15

ARIAD to Webcast Conference Call on Second Quarter 2015 Financial Results

Read More

Our Company Video

A shared commitment to patients and each other. This is ARIAD.

Our Company Video
Print page Share page
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue